NCT02734602View on ClinicalTrials.gov

Imaging SV2A in Mood Disorders

NARecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions
Major Depressive DisorderPost-Traumatic Stress Disorder
Interventions
DRUG

Ketamine

Ketamine will be administered after the initial PET scan for subjects participating in the ketamine aim.

Trial Locations (1)

06519

RECRUITING

PET Center, New Haven

All Listed Sponsors
collaborator

VA Office of Research and Development

FED

lead

Yale University

OTHER